型号:
产品价格:电议      采购度:1649      原产地:美洲
发布时间:2021/11/30 13:25:16 所属地区:国外 国外
简要描述:
APD668 是一种有效的,选择性和具有口服活性的 G 蛋白偶联受体 GPR119 激动剂,对 hGPR119 和 rGPR119 的 EC50 值分别为 nM 和 33 nM。APD668 对除 CYP2C9 (Ki= μM) 以外的五种主要 CYP 亚型均无明显抑制作用。APD668 可用于脂肪性肝炎和糖尿病的研究。
标签:apd-668
产品详情
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
CAS No. : 832714-46-2
MCE 站:APD668
产品活性:APD668 是一种有效的,选择性和具有口服活性的 G 蛋白偶联受体 GPR119 激动剂,对 hGPR119 和 rGPR119 的 EC50 值分别为 2.7 nM 和 33 nM。APD668 对除 CYP2C9 (Ki=0.1 μM) 以外的五种主要 CYP 亚型均无明显抑制作用。APD668 可用于脂肪性肝炎和糖尿病的研究。
研究领域:GPCR/G Protein | Neuronal Signaling | Metabolic Enzyme/Protease | Membrane Transporter/Ion Channel
作用靶点:GPR119 | Cytochrome P450 | Potassium Channel
In Vitro: APD668 increases adenylate cyclase activation in HEK293 cells transfected with human GPR119 in a concentration-dependent manner with an EC50 of 23 nM.
APD668 is highly bound to plasma proteins of male and female cynomolgus monkeys and humans (⩾99%), but is less extensively bound to male (93.0%) and female (96.6%) rats.
In Vivo: APD668 (10-30 mg/kg; p.o. once daily for 8 weeks) significantly reduces blood glucose and glycated hemoglobin (HbA1c) levels, with no desensitization of the acute drug response.
APD668 (1-10 mg/kg; a single p.o.) markedly reduces blood glucose levels during oral glucose tolerance test in a dose-dependent manner in mice.
APD668 (0.08 mg/kg/min; i.v.) shows no effect during euglycemic condition, but significantly stimulates insulin release when blood glucose levels are raised to approximately 300 mg/dl in a hyperglycemic clamp model in the Sprague-Dawley rat.
APD668 (p.o.) exhibits rapid to moderate absorption (tmax≤2 h) in mice, rats, and monkeys, but slower in dogs (tmax=6 h), and moderate to good absolute oral bioavailability (44-79%) in mice, rats, and monkeys, but lower in dogs (22%).
相关产品:Bioactive Compound Library Plus | GPCR/G Protein Compound Library | Membrane Transporter/Ion Channel Compound Library | Metabolism/Protease Compound Library | Neuronal Signaling Compound Library | Anti-Aging Compound Library | Antioxidants Compound Library | Diabetes Related Compound Library | Oxygen Sensing Compound Library | Orally Active Compound Library | Anti-Alzheimer's Disease Compound Library | Neurodegenerative Disease-related Compound Library | Nigericin sodium salt | BAPTA-AM | Verapamil hydrochloride | Apigenin | Branaplam | Fenofibrate | Ketoconazole | 1-Aminobenzotriazole | Rosuvastatin Calcium | SKF-96365 hydrochloride | Itraconazole | Tetrandrine | Glibenclamide | Cobicistat | SCH-23390 hydrochloride | Abiraterone acetate | Amiodarone hydrochloride | PAP-1 | Clarithromycin | TRAM-34 | Minoxidil | Mefloquine hydrochloride | Terfenadine | Atovaquone | DCPIB | Talarozole | 20(S)-Ginsenoside Rg3 | Atazanavir sulfate
品牌介绍:
• MCE (MedChemExpress) 拥有数百种全球独家化合物,我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物;
• 10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域;
• 设有专业的实验中心和严格的质控、验证体系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告,确保产品的高纯度、高品质;
• 产品的生物活性多经各国客户实验验证;
• Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果;
• 专业团队跟踪*新的制药及生命科学研究进展,为您提供全球*新的活性化合物;
• 与世界各大制药公司及知名科研机构建立了长期的合作。
更新时间:2024/1/2 10:19:26
留言咨询
温馨提示
1.遵守中华人民共和国有关法律、法规,尊重网上道德,承担一切因您的行为而直接或间接引起的法律责任。
2.请您真实的反映产品的情况,不要捏造、诬蔑、造谣。如对产品有任何疑问,也可以留言咨询。
3.未经本站同意,任何人不得利用本留言簿发布个人或团体的具有广告性质的信息或类似言论。
相关新闻
相关产品